Abstract
Recent guidelines for the prevention of opportunistic infections have addressed a variety of issues germane to recipients of hematopoietic stem cell transplant. However, there are several issues regarding postexposure prophylaxis against varicella-zoster virus that remain unresolved. We address these questions and offer several consensus recommendations.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Acyclovir / therapeutic use
-
Antiviral Agents / therapeutic use
-
Disease Transmission, Infectious / prevention & control
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Herpesviridae Infections / prevention & control*
-
Herpesviridae Infections / therapy
-
Herpesviridae Infections / transmission
-
Herpesvirus 3, Human
-
Humans
-
Immune Sera
-
Immunization, Passive
-
Immunocompromised Host*
-
Neoplasms / immunology
-
Neoplasms / therapy
-
Opportunistic Infections / prevention & control*
-
Opportunistic Infections / therapy
-
Opportunistic Infections / transmission
-
Practice Guidelines as Topic
-
Secondary Prevention
Substances
-
Antiviral Agents
-
Immune Sera
-
varicella-zoster immune globulin
-
Acyclovir